The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Recurrent vulvovaginal candidiasis
Abstract
Purpose Recurrent vulvovaginal candidiasis (RVVC), multiple episodes of vulvovaginal candidiasis (VVC; vaginal yeast infection) within a 12-month period, adversely affects quality of life, mental health, and sexual activity. Diagnosis is not straightforward, as VVC is defined by the combination of often nonspecific vaginal symptoms and the presence of yeast-which is a common vaginal commensal. Estimating the incidence and prevalence is challenging: most VVC is diagnosed and treated empirically, the availability for purchase of effective therapies over the counter enables self-diagnosis and treatment, and the duration of the relatively benign VVC symptoms is short, introducing errors into any estimates relying on medical records or patient recall.Methods We evaluate current estimates of VVC and RVVC and provide new prevalence estimates using data from a 2011 seven-country (n = 7345) internet panel survey on VVC conducted by Ipsos Health (https://www.ipsos.com/en). We also evaluate information on VVC-associated visits using the National Ambulatory Medical Care Survey.Results The estimated probability of VVC by age 50 varied widely by country (from 23% to 49%, mean 39%), as did the estimated probability of RVVC after VVC (from 14% to 28%, mean 23%).Conclusions However estimated, the probability of RVVC was high suggesting RVVC is a common condition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Because Candida is a common vaginal commensal that can be found in the absence of infection, its presence is not diagnostic in itself. 6”
From Clinical challenges in diagnosis and treatment of recurrent vulvovaginal candidiasis (2022) · cites this paper as [6]
In the citing paper
“Even in women who previously had a clinically diagnosed acute VVC infection, only one-third correctly self-diagnosed a subsequent VVC infection. 6”
From Clinical challenges in diagnosis and treatment of recurrent vulvovaginal candidiasis (2022) · cites this paper as [6]
In the citing paper
“Studies have shown, however, that women often base self-diagnosis on nonspecific symptoms and without a full understanding of the variety of vaginal conditions that can cause similar symptoms. 6”
From Clinical challenges in diagnosis and treatment of recurrent vulvovaginal candidiasis (2022) · cites this paper as [6]
In the citing paper
“Although clinical resistance to antifungal agents remains rare, overexposure to azoles may increase the development of fluconazole-resistant C. albicans strains.”
From Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion (2022) · cites this paper as Blostein et al., 2017
In the citing paper
“According to a recent study, the probability of women developing RVVC in European countries before the age of 50 is 24% (Blostein et al., 2017).”
From Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion (2022) · cites this paper as Blostein et al., 2017
In the citing paper
“Although clinical resistance to antifungal agents remains rare, overexposure to azoles may increase the development of fluconazole-resistant C. albicans strains.”
From Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion (2022) · cites this paper as Blostein et al., 2017
Citations
Cites
Sexually transmitted diseases treatment guidelines (2015)
Workowski, K., & BOLAN, G. A. (2015) · The Scientific Issues of Ternopil Volodymyr Hnatiuk National Pedagogical University Series pedagogy · doi:10.18370/2309-4117.2015.24.51-56 · Cited by 2,684
Sobel, J. D. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60917-9 · Cited by 1,270
Sexually Transmitted Diseases Treatment Guidelines 2002
(2002) · PsycEXTRA Dataset · doi:10.1037/e548482006-001 · Cited by 1,238
National Ambulatory Medical Care Survey: 2001 summary.
Cherry, D. K., Burt, C. W., & Woodwell, D. A. (2003) · PubMed · Cited by 762
Vulvovaginal candidiasis: Epidemiologic, diagnostic, and therapeutic considerations
Sobel, J. D., Faro, S., Force, R. W., Foxman, B., Ledger, W. J., Nyirjesy, P., Reed, B. D., & Summers, P. R. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)80001-x · Cited by 694
Self-citationGoldman, E. B. L., & Schafer, A. I. (2015) · Medical Entomology and Zoology · Cited by 526
Recurrent vulvovaginal candidiasis
Sobel, J. D. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.06.067 · Cited by 502
Sobel, J. D. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712253372607 · Cited by 446
Richter, S. S., Galask, R. P., Messer, S. A., Hollis, R. J., Diekema, D. J., & Pfaller, M. A. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.5.2155-2162.2005 · Cited by 435
Overview of medically important antifungal azole derivatives
Fromtling, R. A. (1988) · Clinical Microbiology Reviews · doi:10.1128/cmr.1.2.187 · Cited by 400
Research works printed but not linked: 5
- Gonzales, 1994, Over-the-Counter histamine 2 bocker therapy, Ann Pharm, 28, 392
- Foxman, 1998, Frequency and response to vaginal symptoms among White and African American women: results of a random digit dialing survey, J Womens Health, 7, 1167, 10.1089/jwh.1998.7.1167 · DOI
- Foxman, 2013, Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey, J Low Genit Tract Dis, 17, 340, 10.1097/LGT.0b013e318273e8cf · DOI · Paper page
- Johnson, 2010, Attitudes and experience of women to common vaginal infections, J Low Genit Tract Dis, 14, 287, 10.1097/LGT.0b013e3181d85bb7 · DOI
- Khosravi, 2011, A comparison study between the direct agglutination test and conventional methods in the diagnosis of vulvovaginal candidiasis, Comp Clin Path, 20, 639, 10.1007/s00580-010-1050-1 · DOI
Cited by
Sorted by citations
Chitosan-based hydrogels: Preparation, properties and applications
Shariatinia, Z., & Jalali, A. M. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.04.034 · Cited by 396
Yano, J., Sobel, J. D., Nyirjesy, P., Sobel, R., Williams, V. L., Yu, Q., Noverr, M. C., & Fidel, P. L. (2019) · BMC Women's Health · doi:10.1186/s12905-019-0748-8 · Cited by 270
Barrientos‐Durán, A., Fuentes, A. P., de Salazar, A., Plaza‐Díaz, J., & García, F. (2020) · Nutrients · doi:10.3390/nu12020419 · Cited by 188
Healthy Vaginal Microbiota and Influence of Probiotics Across the Female Life Span
Lehtoranta, L., Ala‐Jaakkola, R., Laitila, A., & Maukonen, J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.819958 · Cited by 146
Biofilms and vulvovaginal candidiasis
Rodríguez‐Cerdeira, C., Carnero-Gregorio, M., Molares-Vila, A., López-Bárcenas, A., Fabbrocini, G., Bardhi, B., Sinani, A., Sánchez-Blanco, E., Arenas, R., & Hernández‐Castro, R. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.11.011 · Cited by 159
Pathogenesis and Clinical Relevance of Candida Biofilms in Vulvovaginal Candidiasis
Rodríguez‐Cerdeira, C., Martínez-Herrera, E. O., Carnero-Gregorio, M., López-Bárcenas, A., Fabbrocini, G., Fida, M., El-Samahy, M., & González-Cespón, J. L. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.544480 · Cited by 132
Regulation of Candida albicans Hyphal Morphogenesis by Endogenous Signals
Kornitzer, D. (2019) · Journal of Fungi · doi:10.3390/jof5010021 · Cited by 115
Probiotics and vaginal microecology: fact or fancy?
Buggio, L., Somigliana, E., Borghi, A., & Vercellini, P. (2019) · BMC Women s Health · doi:10.1186/s12905-019-0723-4 · Cited by 101
Zeng, X., Zhang, Y., Zhang, T., Xue, Y., Xu, H., & An, R. (2018) · BioMed Research International · doi:10.1155/2018/9703754 · Cited by 98
The mammalian mycobiome: A complex system in a dynamic relationship with the host
Lai, G. C., Tan, T. G., & Pavelka, N. (2018) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1438 · Cited by 92
Martens, M. G., Maximos, B., Degenhardt, T., Person, K., Curelop, S., Ghannoum, M., Flynt, A., & Brand, S. R. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.07.023 · Cited by 86
Ardizzoni, A., Wheeler, R. T., & Pericolini, E. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.692491 · Cited by 89
Donders, G., Sziller, I. O., Paavonen, J., Hay, P., de Seta, F., Bohbot, J. M., Kotarski, J., Vives, J. A., Szabo, B., Cepuliené, R., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.934353 · Cited by 82
Oteseconazole: An Advance in Treatment of Recurrent Vulvovaginal Candidiasis
Sobel, J. D., & Nyirjesy, P. (2021) · Future Microbiology · doi:10.2217/fmb-2021-0173 · Cited by 78
Vulvovaginal Candidosis: Current Concepts, Challenges and Perspectives
Sustr, V., Foessleitner, P., Kiss, H., & Farr, A. (2020) · Journal of Fungi · doi:10.3390/jof6040267 · Cited by 81
Wu, X., Zhang, S., Li, H., Shen, L., Dong, C., Sun, Y., Chen, H., Xu, B., Zhuang, W., Deighton, M. A., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01117 · Cited by 80
Action mechanisms of probiotics on Candida spp. and candidiasis prevention: an update
Ribeiro, F. D. C., Rossoni, R. D., de Barros, P. P., dos Santos, J. D., Fugisaki, L. R. D. O., Leão, M. V. P., & Junqueira, J. (2019) · Journal of Applied Microbiology · doi:10.1111/jam.14511 · Cited by 65
Sardi, J. D. C. O., Silva, D. R., Aníbal, P. C., Baldin, J. J. C. M. D. C., Ramalho, S. R., Rosalen, P. L., Macedo, M. L. R., & Höfling, J. F. (2021) · Current Fungal Infection Reports · doi:10.1007/s12281-021-00415-9 · Cited by 62
Saracino, I. M., Foschi, C., Pavoni, M., Spigarelli, R., Valerii, M. C., & Spisni, E. (2022) · Antibiotics · doi:10.3390/antibiotics11010073 · Cited by 61
Arias, L. S., Pessan, J. P., Neto, F. N. D. S., de Lima, B. H. R., Camargo, E. R., Ramage, G., Delbem, A. C. B., & Monteiro, D. R. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.111080 · Cited by 59
Animal Models and Alternatives in Vaginal Research: a Comparative Review
McCracken, J. M., Calderon, G. A., Robinson, A., Sullivan, C. N., Cosgriff‐Hernandez, E., & Hakim, J. C.-E. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00529-y · Cited by 58
Clinical challenges in diagnosis and treatment of recurrent vulvovaginal candidiasis
Neal, C. M., & Martens, M. G. (2022) · SAGE Open Medicine · doi:10.1177/20503121221115201 · Cited by 56
Uppuluri, P., Singh, S., Alqarihi, A., Schmidt, C. S., Hennessey, J. P., Yeaman, M. R., Filler, S. G., Edwards, J. E., & Ibrahim, A. S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01349 · Cited by 56
Efficacy and Safety of Oteseconazole in Recurrent Vulvovaginal Candidiasis
Sobel, J. D., Donders, G., Degenhardt, T., Person, K., Curelop, S., Ghannoum, M., & Brand, S. R. (2022) · NEJM Evidence · doi:10.1056/evidoa2100055 · Cited by 55
Collins, L. M., Moore, R., & Sobel, J. D. (2020) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000496 · Cited by 55
Lírio, J., Giraldo, P. C., Amaral, R. L., Sarmento, A. C. A., Costa, A. P. F., & Gonçalves, A. K. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027489 · Cited by 53
Pereira, L. C., Correia, A. F., da Silva, Z. D. L., Resende, C. N., Brandão, F., Almeida, R. M., & Nóbrega, Y. K. D. M. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04199-1 · Cited by 55
Spaggiari, L., Sala, A., Ardizzoni, A., Seta, F. D., Singh, D. K., Gácser, A., Blasi, E., & Pericolini, E. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02696-21 · Cited by 56
Martínez, J. J. G., Górriz, J. L., Cuenca, A. M. C., Conde, A. C., & Velasco, M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13216509 · Cited by 54
Melo, C. M., Cardoso, J. F., Perassoli, F., Neto, A. S. D. O., Pinto, L. M., Marques, M. B. D. F., Mussel, W. D. N., de Magalhães, J. T., de Moura, S. A. L., Araújo, M. G. D. F., et al. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2019.115608 · Cited by 48
Benedict, K., Singleton, A. L., Jackson, B. R., & Molinari, N. (2022) · BMC Women s Health · doi:10.1186/s12905-022-01741-x · Cited by 52
Oral Ibrexafungerp: An Investigational Agent for the Treatment of Vulvovaginal Candidiasis
Azie, N., Angulo, D., Dehn, B., & Sobel, J. D. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1791820 · Cited by 46
Gündel, S. D. S., de Godoi, S. N., Santos, R. C. V., da Silva, J. T., Leite, L. B. D. M., Amaral, A. C., & Ourique, A. F. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101762 · Cited by 41
Vulvovaginal candidiasis: An overview of mycological, clinical, and immunological aspects
Jafarzadeh, L., Ranjbar, M., Nazari, T., Eshkaleti, M. N., Gharehbolagh, S. A., Sobel, J. D., & Mahmoudi, S. (2022) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15267 · Cited by 43
How urgent is the need for new antifungals?
Stewart, A. G., & Paterson, D. L. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1935868 · Cited by 36
Shi, Y., Zhu, Y., Fan, S., Liu, X., Liang, Y., & Shan, Y. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-04985-w · Cited by 32
Sala, A., Ardizzoni, A., Spaggiari, L., Vaidya, N., van der Schaaf, J., Rizzato, C., Cermelli, C., Mogavero, S., Krüger, T., Himmel, M., et al. (2023) · mBio · doi:10.1128/mbio.00107-23 · Cited by 34
de Toledo, L. G., Ramos, M. A. D. S., da Silva, P. B., Rodero, C. F., Gomes, V. D. S., da Silva, A. N., Pavan, F. R., da Silva, I. C., Oda, F. B., Flumignan, D. L., et al. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s275258 · Cited by 32
Protective Roles of Honey in Reproductive Health: A Review
Zaid, S. S. M., Ruslee, S. S., & Mokhtar, M. H. (2021) · Molecules · doi:10.3390/molecules26113322 · Cited by 32
Benedict, K., Lyman, M., & Jackson, B. R. (2022) · PLoS ONE · doi:10.1371/journal.pone.0267866 · Cited by 33
Vaginosis: Advances in new therapeutic development and microbiome restoration
Mohankumar, B., Shandil, R. K., Narayanan, S., & Krishnan, U. M. (2022) · Microbial Pathogenesis · doi:10.1016/j.micpath.2022.105606 · Cited by 33
A longitudinal study on fluconazole resistance in Candida albicans vaginal isolates
Sobel, J. D., Sebastian, S., & Boikov, D. A. (2023) · Mycoses · doi:10.1111/myc.13582 · Cited by 34
Sharifi‐Rad, J., Quispe, C., Rahavian, A., Carneiro, J. N. P., Rocha, J. E., Leal, A. L. A. B., Morais‐Braga, M. F. B., Coutinho, H. D. M., Djafari, A. A., Alarcón, P., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.674682 · Cited by 26
Psychosocial impact of recurrent urogenital infections: a review
Thomas-White, K. J., Navarro, P., Wever, F., King, L., Dillard, L. R., & Krapf, J. M. (2023) · Women s Health · doi:10.1177/17455057231216537 · Cited by 29
Ferreira, P. S., Victorelli, F. D., Rodero, C. F., Fortunato, G. C., Araújo, V. H. S., Fonseca‐Santos, B., Bauab, T. M., Dijck, P. V., & Chorilli, M. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120658 · Cited by 25
New Antifungals for Vulvovaginal Candidiasis: What Is Their Role?
Sobel, J. D. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad002 · Cited by 23
Ignjatović, A., Arsić-Arsenijević, V. S., Golubović, M., Đenić, S., Momčilović, S., Trajković, A., Ranđelović, M., Ćirić, V. M., & Otašević, S. (2020) · Journal of Fungi · doi:10.3390/jof6030113 · Cited by 25
Moreira, D., Ruiz, L. D. S., Leite-Jr, D. P., Auler, M. E., Ramos, R. T. B., Costa, V. T., Lara, B. R., Gasparetto, A., Gandra, R. F., Melhem, M. D. S. C., et al. (2021) · Mycopathologia · doi:10.1007/s11046-021-00556-y · Cited by 23
Said, M. M., Watson, C., & Grando, D. (2020) · Scientific Reports · doi:10.1038/s41598-020-60178-0 · Cited by 22
Tropical Medicinal Plant Extracts from Indonesia as Antifungal Agents against Candida Albicans
Geraldi, A., Wardana, A. P., Aminah, N. S., Kristanti, A. N., Sadila, A. Y., Wijaya, N. H., Wijaya, M. R. A., Diningrum, N. I. D., Hajar, V. R., & Manuhara, Y. S. W. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2709274 · Cited by 26
de Carvalho, N. S., Júnior, J. E., Travassos, A. G., Santana, L. B., & Miranda, A. E. (2021) · Epidemiologia e Serviços de Saúde · doi:10.1590/s1679-4974202100007.esp1 · Cited by 23
Genotypic analysis of secreted aspartyl proteinases in vaginal Candida albicans isolates
Lima, J. S., Braga, K. R. G. S., Vieira, C., de Souza, W. W. R., Chavez-Pavoni, J. H., de Araújo, C., & Goulart, L. (2018) · Jornal Brasileiro de Patologia e Medicina Laboratorial · doi:10.5935/1676-2444.20180006 · Cited by 16
Fernandes, T., Baxi, K., Sawarkar, S. P., Sarmento, B. F. C. C., & das Neves, J. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1728251 · Cited by 20
Naeimi, B., Mirhendi, H., Khamisipour, G., Sadeghzadeh, F., & Ahmadi, B. (2018) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000834 · Cited by 19
Vaginal Lactobacillus Impair Candida Dimorphic Switching and Biofilm Formation
Parolin, C., Croatti, V., Giordani, B., & Vitali, B. (2022) · Microorganisms · doi:10.3390/microorganisms10102091 · Cited by 19
Diagnosis and treatment of infectious vaginitis: Proposal for a new algorithm
Eleutério, J., Campaner, A. B., & de Carvalho, N. S. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1040072 · Cited by 18
Sanches, J. M., Giraldo, P. C., Bardin, M. G., do Amaral, R. L. G., Discacciati, M. G., & Rossato, L. T. (2020) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0040-1715139 · Cited by 25
Liu, Z., Yang, H., Huang, R., Li, X., Sun, T., & Zhu, L. (2025) · Clinical Microbiology Reviews · doi:10.1128/cmr.00284-24 · Cited by 17
Recurrent Vulvovaginal Candidosis and Its Underlying Mechanisms: A Systematic Review
Lobo, M., Cerqueira, C., Rodrigues, A. G., & Lisboa, C. (2025) · Journal of Fungi · doi:10.3390/jof11050357 · Cited by 19
Wychrij, D. A., Chapman, T. I., Rayens, E. A., Rabacal, W., Willems, H. M. E., Oworae, K. O., Peters, B. M., & Norris, K. A. (2025) · npj Vaccines · doi:10.1038/s41541-025-01171-4 · Cited by 15
Recurrent Candida Vulvovaginitis
Nsenga, L., & Bongomin, F. (2022) · Venereology · doi:10.3390/venereology1010008 · Cited by 16
Phytotherapy of Vulvovaginal Candidiasis: A Narrative Review
Picheta, N., Piekarz, J., Burdan, O., Satora, M., Tarkowski, R., & Kułak, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073796 · Cited by 20
de Araújo, P. R., Calixto, G. M. F., Araújo, V. H. S., Sato, M. R., Rodero, C. F., Oshiro, J. A., Bauab, T. M., & Chorilli, M. (2021) · Medical Mycology · doi:10.1093/mmy/myab006 · Cited by 14
Shawaky, S. M., Shammari, M. M. A. A., Swelem, M. S., Ghazal, A. A. E. R., & Amer, A. N. (2022) · AIMS Microbiology · doi:10.3934/microbiol.2022014 · Cited by 15
He, R. X., Lin, F., Yu, B., & Huang, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28776 · Cited by 14
Risks for Recurrent Vulvovaginal Candidiasis Caused by Non-Albicans Candida Versus Candida Albicans
Tressler, A. B., Markwei, M. T., Fortin, C. N., Yao, M., Procop, G. W., Soper, D. E., & Goje, O. (2021) · Journal of Women s Health · doi:10.1089/jwh.2020.8811 · Cited by 14
Essential Oil and nanocarrier-based Formulations Approaches for Vaginal Candidiasis
Negi, P., Singh, A., Pundir, S., Parashar, A., Upadhyay, N. K., Agarwal, S., Chauhan, R., & Tambuwala, M. M. (2023) · Therapeutic Delivery · doi:10.4155/tde-2022-0058 · Cited by 15
Current burden of serious fungal infections in Republic of Congo
Amona, F. M., Denning, D. W., Moukassa, D., & Hennequin, C. (2020) · Mycoses · doi:10.1111/myc.13075 · Cited by 12
Li, M., Jin, X., Jiang, Q., Wei, H., Deng, A., Mao, Z., Wang, Y., Zeng, Z., Wu, Y., Liu, S., et al. (2023) · Journal of Fungi · doi:10.3390/jof9121159 · Cited by 12
Tas, G. G., & Satı, L. (2024) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-024-03230-6 · Cited by 11
Wang, L., Zhang, M., Guo, J., Guo, W., Zhong, N., Shen, H., Cai, J., Zhu, Z., & Wu, W. (2021) · Mycologia · doi:10.1080/00275514.2021.1913949 · Cited by 10
Rapisarda, A. M. C., Pino, A., Grimaldi, R. L., Caggia, C., Randazzo, C. L., & Cianci, A. (2023) · Frontiers in Surgery · doi:10.3389/fsurg.2022.1075612 · Cited by 13
Goulart, L. S., Santiago, E. F., Ramon, J. L., de Moura, S. V., Silva, A. R., Silva, I. F., Chávez‐Pavoni, J. H., & de Araújo, C. (2016) · Jornal Brasileiro de Patologia e Medicina Laboratorial · doi:10.5935/1676-2444.20160039 · Cited by 11
Fan, W., Li, J., Chen, L., Wu, W., Li, X., Zhong, W., & Pan, H. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s410128 · Cited by 9
Role of Antifungal Susceptibility Tests in the Treatment of Vulvovaginal Candidiasis
Sobel, J. D. (2023) · Current Infectious Disease Reports · doi:10.1007/s11908-023-00797-6 · Cited by 8
In vitro study to assess modulation of Candida biofilm by Escherichia coli from vaginal strains
Díaz-Navarro, M., Irigoyen-von-Sierakowski, Á., Palomo, M., Escribano, P., Guinea, J., Burillo, A., Galar, A., Muñóz, P., & Guembe, M. (2023) · Biofilm · doi:10.1016/j.bioflm.2023.100116 · Cited by 8
Martínez-García, E., Martínez-Martínez, J. C., Salvador, A. M., González‐García, A., Pérez‐Morente, M. Á., Álvarez‐Serrano, M. A., & García, I. G. (2023) · Pathogens · doi:10.3390/pathogens12060756 · Cited by 10
Vaccalluzzo, A., Pino, A., Grimaldi, R. L., Caggia, C., Cianci, S., & Randazzo, C. L. (2024) · Journal of Applied Microbiology · doi:10.1093/jambio/lxae110 · Cited by 8
A Prerequisite for Health: Probiotics
Rossoni, R. D., Ribeiro, F. D. C., de Barros, P. P., Mylonakis, E. E., & Junqueira, J. C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816664-2.00011-6 · Cited by 9
Recurrent Vulvovaginal Candidiasis
Sovianti, C. S., & Devi, M. (2021) · Bioscientia Medicina Journal of Biomedicine and Translational Research · doi:10.32539/bsm.v5i3.280 · Cited by 8
Spaggiari, L., Ramos, G. B. S., Ramos, C. A. S., Ardizzoni, A., Pedretti, N., Blasi, E., Seta, F. D., & Pericolini, E. (2023) · Microorganisms · doi:10.3390/microorganisms11061551 · Cited by 7
Otoo-Annan, E., & Senoo-Dogbey, V. E. (2024) · BMC Public Health · doi:10.1186/s12889-024-17668-x · Cited by 7
Research progress of hydrogels in the prevention of pelvic inflammatory disease
Xiao, Y., Ma, T., Wu, H., Su, Q., Zhou, Y., Zhou, B., Yang, K., Pu, Z., Feng, W., Yong, X., et al. (2024) · MedComm – Biomaterials and Applications · doi:10.1002/mba2.100 · Cited by 8
Ricchi, F., Kenno, S., Pedretti, N., Brenna, G., Seta, F. D., Ardizzoni, A., & Pericolini, E. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1578831 · Cited by 7
Intravaginal Gel for Sustained Delivery of Occidiofungin and Long-Lasting Antifungal Effects
Cothrell, A., Cao, K., Bonasera, R., Tenorio, A., Orugunty, R. S., & Smith, L. (2023) · Gels · doi:10.3390/gels9100787 · Cited by 7
Jothi, R., & Gowrishankar, S. (2024) · The Journal of Antibiotics · doi:10.1038/s41429-024-00728-0 · Cited by 7
Treatment of Recurrent Vulvovaginal Candidiasis With Ibrexafungerp
Grant, L. M., & Orenstein, R. (2022) · Journal of Investigative Medicine High Impact Case Reports · doi:10.1177/23247096221123144 · Cited by 7
Ranawaka, R. R. (2020) · Springer eBooks · doi:10.1007/978-981-15-5483-4_17 · Cited by 7
Chauhan, V., Kumar, A., Tripathi, S., Jha, M., Kumar, N., Poluri, K. M., & Gupta, P. (2024) · Discover Public Health · doi:10.1186/s12982-024-00274-y · Cited by 7
The Role of TLR2/TLR4 Receptors in Host Genetic Susceptibility to Recurrent Vulvovaginitis
Routsias, J. G., Verra, C., Tsiakalos, A., Tsakris, A., & Mavrouli, M. D. (2025) · Journal of Fungi · doi:10.3390/jof11110804 · Cited by 7
Blaganje, M., & Barbič, M. (2020) · Current Bladder Dysfunction Reports · doi:10.1007/s11884-020-00606-z · Cited by 7
Recurrent Infectious Vaginitis
Yazdy, G. M., Mitchell, C. M., Sobel, J. D., & Tuddenham, S. (2023) · Medical Clinics of North America · doi:10.1016/j.mcna.2023.08.017 · Cited by 5
Korabi, M. N. A., Mirmolaei, S. T., Tabarrai, M., Attar, S. M. G., Lamardi, S. N. S., & Haghani, S. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/1739729 · Cited by 5
Vaginal homeostasis features of Vulvovaginal Candidiasis through vaginal metabolic profiling
Chen, X., Wang, J., Chen, J., Wang, G., Zhang, R., & Qiu, J. (2023) · Medical Mycology · doi:10.1093/mmy/myad085 · Cited by 5
Zhang, J., Jiang, X., Shi, G., Zhang, H., Hu, K., Wu, D., Shao, J., Liu, T., Wang, T., & Wang, C. (2024) · Fitoterapia · doi:10.1016/j.fitote.2024.105825 · Cited by 5
Brazilian Protocol for Sexually Transmitted Infections, 2020: infections causing vaginal discharge
de Carvalho, N. S., Eleutério, J., Travassos, A. G., Santana, L. B., & Miranda, A. E. (2021) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-593-2020 · Cited by 4
Antifungal Efficacy of Plant Essential Oils Against Candida, Aspergillus and Cryptococcus Species
Kumari, K. M. U., Imam, M. W., & Luqman, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-5165-5_5 · Cited by 4
Drug-loaded electrospun nanofiber for Vulvovaginal candidiasis: A systematic literature review
Vidyadhari, A., Singh, A. K., Ralli, T., Parvez, S., & Kohli, K. (2023) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2023.101420 · Cited by 4
Sustained Efficacy of Oteseconazole in Women with Recurrent Vulvovaginal Candidiasis
Lederman, S. N., Sobel, R., Sobel, J. D., Curelop, S., & Brand, S. R. (2025) · Journal of Women s Health · doi:10.1177/15409996251394811 · Cited by 3
Song, Y., & Li, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-818619-0.00083-6 · Cited by 3
Metadata
- Authors
- Blostein, F., Levin-Sparenberg, E., Wagner, J., & Foxman, B.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Foxman, Betsy
- Venue
- Annals of Epidemiology
- Publisher
- Elsevier BV
- Published
- 2017-09
- Volume
- 27
- Issue
- 9
- Pages
- 575-582.e3
- ISSN
- 1047-2797 (ISSN-L)
- OpenAlex
- W2746230075
- Cited by
- 180
- References
- 77
- Citations by year
- 2026: 13 · 2025: 18 · 2024: 25 · 2023: 27 · 2022: 30 · 2021: 23 · 2020: 23 · 2019: 12 · 2018: 8
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- NovaDigm Therapeutics
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Urology › Urinary Tract Infections Management
- Keywords
- recurrent vulvovaginal candidiasis, vaginal candidiasis, prevalence, incidence, National Ambulatory Medical Care Survey, yeast infections, quality of life, sexual activity
- MeSH terms
- Antifungal Agents, Candidiasis, Vulvovaginal, Female, Humans, Quality of Life, Recurrence, Sexual Behavior, Vagina, Incidence, Prevalence, Age Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
